Pluvicto Side Effects
Generic name: lutetium lu 177 vipivotide tetraxetan
Medically reviewed by Drugs.com. Last updated on Dec 28, 2024.
Note: This document provides detailed information about Pluvicto.
Applies to lutetium lu 177 vipivotide tetraxetan: intravenous solution Side Effects associated with lutetium lu 177 vipivotide tetraxetan. Some dosage forms listed on this page may not apply specifically to the brand name Pluvicto.
Applies to lutetium lu 177 vipivotide tetraxetan: intravenous solution.
Precautions
It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly. Blood and urine tests may be needed to check for unwanted effects.
Male patients who have female partners should use effective birth control during treatment with this medicine and for at least 14 weeks after the last dose. If you think your partner has become pregnant while using this medicine, tell your doctor right away.
While receiving this medicine, you will be exposed to radiation and increase risk of cancer. If you have any questions about this, talk to your doctor.
Lutetium Lu 177 vipivotide tetraxetan will lower the number of some types of blood cells in your body. Because of this, you may bleed or get infections more easily. To help with these problems, avoid being near people who are sick or have infections. Wash your hands often. Stay away from rough sports or other situations where you could be bruised, cut, or injured. Brush and floss your teeth gently. Be careful when using sharp objects, including razors and fingernail clippers.
This medicine may cause serious kidney problems. Check with your doctor right away if you have agitation, blood in the urine, coma, confusion, decreased urine output, depression, dizziness, headache, irritability, lethargy, muscle twitching, nausea, rapid weight gain, seizures, stupor, swelling of the face, ankles, or hands, or unusual tiredness or weakness.
Some men who use this medicine have become infertile (unable to have children). Talk with your doctor before using this medicine if you plan to have children.
Serious side effects of Pluvicto
Along with its needed effects, lutetium lu 177 vipivotide tetraxetan (the active ingredient contained in Pluvicto) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking lutetium lu 177 vipivotide tetraxetan:
More common side effects
- black, tarry stools
- bladder pain
- bleeding gums
- bloating or swelling of the face, arms, hands, lower legs, or feet
- blood in the urine or stools
- bloody or cloudy urine
- difficult, burning, or painful urination
- lower back or side pain
- pale skin
- pinpoint red spots on the skin
- rapid weight gain
- tingling of the hands or feet
- trouble breathing
- unusual bleeding or bruising
- unusual tiredness or weakness
- unusual weight gain or loss
Less common side effects
- anxiety
- chest pain or tightness
- chills
- confusion
- coughing up blood
- difficulty in breathing or swallowing
- dizziness
- fainting
- fast heartbeat
- fever
- headache
- increased menstrual flow or vaginal bleeding
- lightheadedness
- nosebleeds
- paralysis
- prolonged bleeding from cuts
- sore throat
- sores, ulcers, or white spots on the lips or in the mouth
- swollen glands
Rare side effects
- blurred vision
- dark-colored urine
- irregular heartbeat
- light-colored stools
- nausea and vomiting
- stomach pain, continuing
- yellow eyes or skin
Other side effects of Pluvicto
Some side effects of lutetium lu 177 vipivotide tetraxetan may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- change in taste
- constipation
- decreased appetite
- diarrhea
- dry mouth
- loss of taste
For healthcare professionals
Applies to lutetium lu 177 vipivotide tetraxetan: intravenous solution.
General adverse events
The most common adverse reactions reported with this drug (plus best standard of care) were fatigue, dry mouth, nausea, anemia, decreased appetite, and constipation; the most common laboratory abnormalities that worsened from baseline were decreased lymphocytes, decreased hemoglobin, decreased leukocytes, decreased platelets, decreased calcium, and decreased sodium. Serious adverse reactions included hemorrhage, musculoskeletal pain, sepsis, anemia, urinary tract infection, acute kidney injury, pneumonia, pancytopenia, pyrexia, spinal cord compression, and pulmonary embolism; fatal adverse reactions included sepsis, pancytopenia, hepatic failure, intracranial hemorrhage, subdural hematoma, ischemic stroke, coronavirus disease 2019 (COVID-19), and aspiration pneumonia.[Ref]
Hematologic
- Very common (10% or more): Decreased lymphocytes (up to 85%), decreased hemoglobin (up to 63%), decreased leukocytes (up to 56%), decreased platelets (up to 45%), anemia (up to 32%), decreased neutrophils (up to 28%), thrombocytopenia (up to 17%)
- Frequency not reported: Pancytopenia (including bicytopenia), leukopenia (including neutropenia)[Ref]
In clinical trials, Grade 3 or 4 decreased hemoglobin (15%), decreased platelets (9%), decreased leukocytes (7%), and decreased neutrophils (4.5%) occurred in patients treated with this drug. Grade 3 or higher pancytopenia (including 2 fatal events) occurred in 1.1% of patients treated with this drug. There were 2 deaths (0.4%) due to intracranial hemorrhage and subdural hematoma associated with thrombocytopenia and 1 death due to sepsis and concurrent neutropenia in patients who received this drug.[Ref]
Other
- Very common (10% or more): Fatigue (up to 43%); decreased calcium (up to 39%), decreased sodium (up to 33%), increased potassium (up to 24%), weight decreased (up to 11%), increased sodium (up to 11%)
- Common (1% to 10%): Peripheral edema (included peripheral edema, fluid retention, fluid overload), pyrexia, sepsis[Ref]
Gastrointestinal
- Very common (10% or more): Dry mouth (included dry mouth, aptyalism, dry throat; up to 39%), nausea (up to 35%), constipation (up to 20%), vomiting (included vomiting, retching; up to 19%), diarrhea (up to 19%), abdominal pain (included abdominal pain, upper abdominal pain, abdominal discomfort, lower abdominal pain, abdominal tenderness, gastrointestinal pain; up to 11%)[Ref]
Hepatic
- Very common (10% or more): Increased AST (up to 28%)
- Frequency not reported: Hepatic failure[Ref]
Renal
- Very common (10% or more): Increased creatinine (up to 24%)
- Common (1% to 10%): Acute kidney injury (included blood creatinine increased, acute kidney injury, renal failure, blood urea increased)[Ref]
In clinical trials, Grade 3 or 4 acute kidney injury and increased creatinine occurred in 3% and 0.9% of patients treated with this drug, respectively.[Ref]
Metabolic
- Very common (10% or more): Decreased appetite (up to 21%)[Ref]
Genitourinary
- Very common (10% or more): Urinary tract infection (included urinary tract infection, cystitis, bacterial cystitis; up to 12%)[Ref]
Nervous system
- Common (1% to 10%): Dizziness, headache, dysgeusia (included dysgeusia, taste disorder), spinal cord compression
- Frequency not reported: Vertigo, intracranial hemorrhage, subdural hematoma, ischemic stroke[Ref]
Cardiovascular
- Common (1% to 10%): Hemorrhage[Ref]
Musculoskeletal
- Common (1% to 10%): Musculoskeletal pain[Ref]
Respiratory
- Common (1% to 10%): Pneumonia, pulmonary embolism
- Frequency not reported: COVID-19, aspiration pneumonia[Ref]
Ocular
- Frequency not reported: Dry eye[Ref]
See also:
Premarin
Premarin is used to treat symptoms of menopause such as hot flashes, and vaginal dryness. Learn ...
Estrace
Estrace (estradiol) is used to treat symptoms of menopause such as hot flashes and vaginal dryness ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Xtandi
Xtandi (enzalutamide) is an anti-androgen used to treat prostate prostate cancer. Includes Xtandi ...
Zytiga
Zytiga (abiraterone) is used together with prednisone to treat prostate cancer that has spread to ...
Casodex
Casodex (bicalutamide) is an anti-androgen and is used together with LHRH to treat prostate cancer ...
Lynparza
Lynparza (olaparib) is used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate ...
Cyclophosphamide
Cyclophosphamide systemic is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia ...
Bicalutamide
Bicalutamide is a prescription medicine used to treat prostate cancer; Includes bicalutamide side ...
Abiraterone
Abiraterone is used along with prednisone or methylprednisolone to treat prostate cancer. Includes ...
References
1. (2022) "Product Information. Pluvicto (lutetium Lu 177 vipivotide tetraxetan)." Advanced Accelerator Applications
More about Pluvicto (lutetium lu 177 vipivotide tetraxetan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: therapeutic radiopharmaceuticals
Patient resources
Professional resources
Related treatment guides
Further information
Pluvicto side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.